Patents by Inventor Regis Vanderesse

Regis Vanderesse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyropheophorbide conjugate and use thereof in the treatment of cancer and as a fluorescent marker
    Patent number: 11975072
    Abstract: The invention relates to a compound of formula (I) and to the pharmaceutically acceptable salts thereof. The invention also relates to the use of said compound of formula (I) in the treatment of cancer, particularly by photodynamic therapy.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: May 7, 2024
    Inventors: Henri Azais, Pierre Collinet, Nadira Delhem-Fellahi, Olivier Morales, Serge Mordon, Céline Frochot, Régis Vanderesse, Aurélie Stallivieri
  • PYROPHEOPHORBIDE CONJUGATE AND USE THEREOF IN THE TREATMENT OF CANCER AND AS A FLUORESCENT MARKER
    Publication number: 20220378914
    Abstract: The invention relates to a compound of formula (I) and to the pharmaceutically acceptable salts thereof. The invention also relates to the use of said compound of formula (I) in the treatment of cancer, particularly by photodynamic therapy.
    Type: Application
    Filed: July 20, 2018
    Publication date: December 1, 2022
    Inventors: Henri AZAIS, Pierre COLLINET, Nadira DELHEM-FELLAHI, Olivier MORALES, Serge MORDON, Céline FROCHOT, Régis VANDERESSE, Aurélie STALLIVIERI
  • Novel Proteasome Modulators
    Publication number: 20080076718
    Abstract: The invention relates to novel proteasome activity modulating molecules which are used in pharmaceutical and cosmetic compositions for preventing and/or treating proteasome-induced pathologies and disorders.
    Type: Application
    Filed: December 17, 2004
    Publication date: March 27, 2008
    Inventors: Michele Reboud-Ravaux, Elise Bernard, David Papapostolou, Regis Vanderesse